Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)Dan H. Barouch, Ludo Lavreys, David C. Montefiori et al.|The Lancet|2018Cited by 342
Clinical Outcomes and Improved Survival in Patients With Protein-Losing Enteropathy After the Fontan OperationAnitha S. John, Frank Cetta, Jennifer Johnson et al.|Journal of the American College of Cardiology|2014Cited by 224
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)Lindsey R. Baden, Dan H. Barouch, Stephen R. Walsh et al.|The Journal of Infectious Diseases|2012Cited by 168
Identifying predictors of hepatic disease in patients after the Fontan operation: A postmortem analysisJennifer Johnson, Anitha S. John, Frank Cetta et al.|Journal of Thoracic and Cardiovascular Surgery|2012Cited by 103
Induction of HIV-1–Specific Mucosal Immune Responses Following Intramuscular Recombinant Adenovirus Serotype 26 HIV-1 Vaccination of HumansLindsey R. Baden, Dan H. Barouch, Jinyan Liu et al.|The Journal of Infectious Diseases|2014Cited by 64